Subscribe
12 September 2014Americas

Kilpatrick Townsend adds Life sciences specialist to team

Law firm Kilpatrick Townsend & Stockton LLP has bolstered its Californian team with the appointment of a new pharmaceutical IP specialist.

William Leschensky (pictured) will join the firm's Silicon Valley office as counsel in its corporate team.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Kilpatrick Townsend expands patent litigation team
21 October 2021   Law firm Kilpatrick Townsend & Stockton has announced the addition of Stuart Pollack to the firm’s New York office as a partner on the patent litigation team.


Editor's picks

Americas
Bernie Sanders blasts big pharma for ‘ripping off’ patients
8 February 2024

Editor's picks

Americas
Bernie Sanders blasts big pharma for ‘ripping off’ patients
8 February 2024
Americas
Pfizer and BioNTech allege inconsistencies in Moderna’s COVID-19 statements
1 February 2024
Biotechnology
Force pharma companies to provide drugs for rare cancer trials, UK govt told
30 January 2024
Biotechnology
USPTO hands win to Daiichi Sankyo in cancer drug dispute
18 January 2024
Americas
SCOTUS urged to remedy ‘threat’ to patent law in sleep drug feud
16 January 2024
Big Pharma
SCOTUS rejects big pharma’s challenge to USPTO power
9 January 2024

More on this story

Americas
Kilpatrick Townsend expands patent litigation team
21 October 2021   Law firm Kilpatrick Townsend & Stockton has announced the addition of Stuart Pollack to the firm’s New York office as a partner on the patent litigation team.

More on this story

Americas
Kilpatrick Townsend expands patent litigation team
21 October 2021   Law firm Kilpatrick Townsend & Stockton has announced the addition of Stuart Pollack to the firm’s New York office as a partner on the patent litigation team.

More features

CureVac and Acuitas wind up COVID-19 vaccine dispute
Amgen and Sandoz settle dispute over blockbuster bone condition drugs
GSK: Pfizer, BioNTech ‘reaped billions of dollars’ from stealing COVID-19 patents
GSK settles HIV drug licensing dispute
Meeting the cell and gene therapy scale-up challenge
Bio-Techne loses UK patent bid and heads to UPC
US Supreme Court denies Vanda's bid to revive sleep drug patents
ProQR defends RNA editing platform at EPO